From: Advances of nano drug delivery system for the theranostics of ischemic stroke
Nanocarriers | Categories of materials | Drugs or agents | Targeting ligands | Results | Refs. |
---|---|---|---|---|---|
Polymeric nanoparticles | Glutathione-coated PLGA-b-PEG | Thyroid hormones (T3) | Glutathione | Protect brain against ischemic injury | [89] |
 | Cationic lipid assisted PEG-PLA | C3-siRNA | _ | Inhibit microglial neurotoxicity | [90] |
 | Chitosan | bFGF and z-DEVD-FMK | Transferrin | Reduce infarct volume in brain | [92] |
 | Tween80 coated chitosan-NIPAAM | Riluzole | _ | Protect brain against ischemic injury | [93] |
 | _ | Melanin | _ | ROS scavenging and anti -inflammation-related | [96] |
Polymeric micelles | Copolymer PEG-b-(PELG-g-PLL) | TNF-α |  | Attenuate the oxidative stress injury, the inflammation-related activity and the apoptosis level in I/R-induced cerebral injury | [104] |
 | Agonistic micelles | Edaravone | _ | Regulate the BBB permeability and deliver neuroprotectants | [105] |
Dendrimers | Arginine ester of PAMAM | siRNA | _ | Perform siRNA-mediation gene knockdown in brain | [112] |
 | cationic PAMAM | _ | _ | Protect the injured brain from stroke by reaching the ischemic neurons | [110] |
Nano-hydrogels | Alginate | VEGF | _ | Induce significant functional and structural protection from ischemic injury | [119] |
Liposomes | Phosphatidylethanolamine(PE), cholesterol, dicetylphosphate | CDP-Choline | _ | Prevent age related global moderate cerebral ischemia reperfusion | [127] |
 | PEG-coated inositol hexaphosphate | Hemoglobin | _ | Reduce ischemia reperfusion injury | [128] |
 | DPPC and cholesterol | Urokinase | Cyclic RGD | Improve the thrombolytic efficacy | [129] |
 | DPPC, cholesterol, PEG2000-PE | Minocycline | _ | Reduce TNF-α induced MMP-9 release | [132] |
 | DSPC, DPPC, cholesterol, DSPE-PEG2000 | FK506 (Tacrolimus) | _ | Reduce cerebral cell apoptosis and ameliorate motor function deficits | [133] |
 | DPPC, Egg-PC, DPPG, cholesterol, PEG2000-PE | Xenon (Xe) | _ | Reduce infarct size in brain | [135] |
 | Bean lecithin, cholesterol, DSPE-PEG2000 | ZL006 | Stroke homing peptide (SHp) and T7 peptide | Block nNOS-PSD-95 association and reduce infarct size in brain | [140] |
Solid lipid nanoparticles | Monostearin, medium-chain triglyceride, polyethylene glycol monostearate | 3-n-Butylphthalide | Fas ligand antibody | Improve brain injury and neurological function | [145] |
 | tripalmitin, Gelucires, vitamin E, phospholipids, and poloxamer 188 | Baicalein |  | improve baicalein's stability and the ability of baicalein to penetrate the brain | [146] |
 | PEGylated cationic solid lipid nanoparticles | Baicalein | OX26 | elevate biological availability of baicalin in cerebral spinal fluid of mice under the cerebral ischemia–reperfusion injury | [147] |
Inorganic nanocarriers | Silica-coated superparamagnetic iron oxide | Endothelial progenitor cells (EPCs) | _ | Improve neurobehavioral outcomes and reduce brain atrophic volume | [151] |
 | _ | Amino-modificated carbon nano-scale tubes (CNTs) | _ | Decrease cell apoptosis in the brain area | [162] |
 | Silica-coated Au or lipophilic polyaspartic acid-based polymer | Vitamin C | _ | ROS scavenging | [163] |
 | _ | Platinum | _ | ROS scavenging | [164] |
 | _ | Cerium oxide | _ | ROS scavenging | [166] |
Cell-derived biomimetic nanocarriers | Exosomes purified from BM-MSCs | microRNAs (miRNAs) | RVG-Lamp2b | Target delivery of gene drugs to the brain for ischemic brain | [174] |
 | Exosomes purified from BM-MSCs | Curcumin | c(RGDyK) peptide | Target delivery of curcumins to the brain for ischemic brain | [175] |
 | Mesenchymal stem cells (MSCs) | MiR-133b | Palmitic acid-peptide | Target delivery of miR-133b to increase the expression level in an ischemic lesion and further improve curative effects | [176] |
 | Dextran polymer core modified with RBC membrane shell | NR2B9C | Stroke homing peptide (SHp) | Reduce ischemia reperfusion injury | [180] |
 | Mn3O4@nanoerythrocyte | _ | T7 | Remodel the stroke microenvironment through self-adapted oxygen regulating and free radical scavenging | [181] |
 | γ-Fe2O3 magnetic nanoparticles inspired by natural platelets | L-arginine | _ | Target adhesion to the injured brain blood vessel during formation of thrombus | [184] |
 | Acetal Modified Dextran modified with platelet membrane shell | ZL006e and tPA | Cell-penetrating peptide | Enhance the treatment of thrombolytics and neuroprotectant for IS | [185] |
 | Neutrophil-mediation cross-linked dendrigraft poly-L-lysine (DGL) nanoparticles | Catalase | PGP ligands | Protect the catalase enzymatic activity from degradation and well transport to receiver cells | [188] |
 | Neutrophil membrane-derived nanovesicles | Resolvin D2 (RvD2) | _ | Enhance resolution of inflammation, thus protecting brain injury during IS | [189] |
 | Neutrophils-derived liposomes system | Puerarin | - | Enhance the neuro-protection effect at the ischemic penumbra | [190] |
Other functional nanocarriers | Copolyoxalate (H2O2-responsive) | Vanillyl alcohol(VA) | _ | Exert anti-inflammation-related and anti-apoptotic activities | [191] |
 | B-PDEA (ROS-responsive) | Neural stem cells (NSCs) | _ | Lead to efficient expression of brain derived neurotrophic factors | [192] |
 | PLA-coated mesoporous silica (ROS-responsive) | Resveratrol | Low-density lipoprotein receptor (LDLR) | Enhance the transcytosis across the blood–brain barrier | [193] |
 | Methoxy poly(ethylene glycol)-poly(L-ethionine) diblock copolymers (H2O2-responsive) | Rhodamine-6G | _ | Serve as promising platforms for sustained drug delivery for diseases with local oxidative stress | [194] |
 | Methoxy poly(ethylene glycol)-poly(β-amino ester) (PEG-PAE) with piperidine and imidazole rings (pH-responsive) | Human serum albumin (HSA) | _ | Target the acidic environment in brain | [196] |
 | Poly (urethane amino sulfamethazine) (PUASM) (pH-responsive) | Stromal cell derived from factor-1α | _ | Modify the microenvironment to increase innate neurorestorative processes | [197] |